Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Preliminary efficacy and safety studies with panamesine in schizophrenia

July 7, 1997

Duloxetine not different from placebo in double-blind depression study

July 7, 1997

Phase III trials show significant positive effect for sertindole on negative symptoms

July 7, 1997

Summary of perospirone clinical trials

July 7, 1997

Selective dopamine autoreceptor agonists prepared by American Home Products

July 7, 1997

SM-13496 preferentially affects mesocortical dopaminergic system

July 4, 1997

Cholinesterase inhibition with metrifonate studied in rats

July 4, 1997

Citicoline improves cognitive impairment in animals and elderly subjects

July 4, 1997

CRF modulator introduced in Italy

July 4, 1997

CCK-B antagonist is not effective in anxiety disorders

July 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...